<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Red cell <z:chebi fb="3" ids="16335">adenosine</z:chebi> deaminase (<z:chebi fb="36" ids="39048">ADA</z:chebi>-RBC) activity in patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> and <z:hpo ids='HP_0004818'>paroxysmal nocturnal hemoglobinuria</z:hpo> is significantly increased compared to that observed in <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="36" ids="39048">ADA</z:chebi>-RBC activity is not related to fetal <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> concentration, but it is significantly correlated with <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> concentration at diagnosis and with the degree of morphologic <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in the erythroid lineage </plain></SENT>
<SENT sid="2" pm="."><plain>The results of our study suggest that the observed enzymatic abnormality may constitute a non-specific manifestation of the stem cell alteration that determines these disorders </plain></SENT>
</text></document>